Related Experiment Video

Updated: Jun 12, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Evidence-based medicine and multiple sclerosis: figures and stories

Jürg Kesselring1

  • 1Department of Neurology and Neurorehabilitation, Rehabilitation Centre, Valens, Switzerland. j.kesselring@klinik-valens.ch

Neuroepidemiology
|June 17, 2010
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Related Experiment Videos

Last Updated: Jun 12, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Articles linked to this work by shared authors, journal, and citation graph.

Incidence of multiple sclerosis in Switzerland - results from the Swiss multiple sclerosis registry.

Multiple sclerosis and related disorders·2026

Development of a core outcome set for the trials of complementary therapies in people with multiple sclerosis: international survey and consensus meetings.

BMJ open·2025

Rising Prevalence of Multiple Sclerosis in Switzerland: Results from the Swiss Multiple Sclerosis Registry.

Neuroepidemiology·2024

Natural language processing analysis of the theories of people with multiple sclerosis about causes of their disease.

Communications medicine·2024

Summary of Research: Caregiver Involvement in MS: Duty or Disruption?

Neurology and therapy·2023

Feelings of loneliness, COVID-19-specific-health anxiety and depressive symptoms during the first COVID-19 wave in Swiss persons with multiple sclerosis.

Scientific reports·2022

Motor Neuron Disease Mortality in the United States, 2010-2023: A demographic, geographic, and temporal analysis.

Neuroepidemiology·2026

The Evolving Premature Burden of Ischemic Stroke (GBD 2023) Among Adults Aged 50-69 Years in China, India, and the United States: A 34-Year Predictive Analysis Based on YLL/YLD Decomposition and ARIMA Models (1990-2053).

Neuroepidemiology·2026

Prevalence of neuromyelitis optica spectrum disorder in Fujian, China, 2021-2023: a population-based study.

Neuroepidemiology·2026

Bibliometric Analysis of Global Research Activity on Stroke Mortality: 1961-2024.

Neuroepidemiology·2026

Revisiting the Link Between Huntington's Disease and Cancer: Evidence from the Enroll-HD dataset.

Neuroepidemiology·2026

Association of maternal nighttime artificial light exposure with children's neurodevelopment: A Chinese birth cohort study.

Neuroepidemiology·2026

Percutaneous transesophageal gastric catheter removal and follow up: A case series.

Radiology case reports·2026

Hyperspectral Camera Imaging Tandem With HPLC-UV-ELSD Determination and Cell Bioassay for Geographical Discrimination and Quality Consistency Evaluation of Anoectochilus roxburghii.

Phytochemical analysis : PCA·2026

Perception among adult sickle cell patients on the use of herbal medicine in the management of sickle cell disease in Ghana: a qualitative study.

Journal of community genetics·2026

INVESTIGATING THE PERSPECTIVES OF RESPIRATORY PHYSICIANS ON HOW SOCIAL DETERMINANTS OF HEALTH AND HEALTH LITERACY INFLUENCE ASTHMA OUTCOMES: A QUALITATIVE STUDY.

Georgian medical news·2026

Electroacupuncture preconditioning at PC6 or ST36 alleviates myocardial inflammation and promotes M2 macrophage phenotypic polarization via distinct autonomic pathways.

Acupuncture in medicine : journal of the British Medical Acupuncture Society·2026

Patient-centered approaches in psoriasis management: lessons from the past and future directions.

Expert opinion on biological therapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us